Search Results - Yanxiang Wang

Synthesis and biological evaluation of new 13-n-nonylprotoberberine derivatives as antitubercular agents by Yinghong Li, Yanxin Liu, Yanxiang Wang, Sheng Tang, Danqing Song

Connect to this object online.

Synthesis and biological evaluation of 8-substituted berberine derivatives as novel anti-mycobacterial agents by Yanxiang Wang, Haigen Fu, Yinghong Li, Jiandong Jiang, Danqing Song

Connect to this object online.

Self-assembled filomicelles prepared from polylactide-poly(ethylene glycol) diblock copolymers for sustained delivery of cycloprotoberberine derivatives by Xue Liu, Yanxiang Wang, Peng Yun, Xin Shen, Feng Su, Yangsheng Chen, Suming Li, Danqing Song

Connect to this object online.

Synthesis and biological evaluation of novel tricyclic matrinic derivatives as potential anti-filovirus agents by Xin Zhang, Qiang Liu, Qianqian Li, Yinghong Li, Zhandong Liu, Hongbin Deng, Sheng Tang, Yanxiang Wang, Youchun Wang, Danqing Song

Connect to this object online.

Evaluation and mechanism study of Pien Tze Huang against EV-A71 infection by Huiqiang Wang, Fenbei Chen, Shicong Wang, Yuhuan Li, Ting Liu, Yinghong Li, Hongbin Deng, Jingwen Dong, Jing Pang, Danqing Song, Dousheng Zhang, Juan Yu, Yanxiang Wang

Connect to this object online.

Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects by Wei Wei, Qingxuan Zeng, Yan Wang, Xixi Guo, Tianyun Fan, Yinghong Li, Hongbin Deng, Liping Zhao, Xintong Zhang, Yonghua Liu, Yulong Shi, Jingyang Zhu, Xican Ma, Yanxiang Wang, Jiandong Jiang, Danqing Song

Connect to this object online.

Author correction to 'Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects' [Acta Pharmaceutica Sinica B 13 (2023) 2138-2151] by Wei Wei, Qingxuan Zeng, Yan Wang, Xixi Guo, Tianyun Fan, Yinghong Li, Hongbin Deng, Liping Zhao, Xintong Zhang, Yonghua Liu, Yulong Shi, Jingyang Zhu, Xican Ma, Yanxiang Wang, Jiandong Jiang, Danqing Song

Connect to this object online.

Evolution and development of potent monobactam sulfonate candidate IMBZ18g as a dual inhibitor against MDR Gram-negative bacteria producing ESBLs by Zhiwen Li, Zhihao Guo, Xi Lu, Xican Ma, Xiukun Wang, Rui Zhang, Xinxin Hu, Yanxiang Wang, Jing Pang, Tianyun Fan, Yonghua Liu, Sheng Tang, Haigen Fu, Jingpu Zhang, Yinghong Li, Xuefu You, Danqing Song

Connect to this object online.